Glucose Monitors, GLP-1s, and the Illusion of "Optimal" Health
Tue Jan 20 2026
CGMs and GLP-1s are everywhere right now, but should everyone be using them? In this episode, Andrew Wade, registered dietitian and CEO of Case Specific Nutrition, is joined by Brad and Hillary, both registered dietitians and lead clinicians at their own offices, to break down the most common question they hear in practice: should non-diabetics get a CGM to improve their health?
Together, they explore how to interpret CGM data, the risks of chasing numbers without context, and what happens when "optimization" replaces foundational health behaviors. The conversation also covers the growing role of GLP-1 medications, recent updates around accessibility and pricing, and why cost reductions can be both a promising step forward and a potential risk depending on how these medications are used.
Brad and Hillary react to the explosion of GLP-1 content on social media, including patches, supplements, and "natural" protocols, and unpack ingredient obsessions like probiotics and Akkermansia. Through real client stories, they challenge weight loss expectations, highlight why eating more, building muscle, and fueling adequately can sometimes drive better results, and reinforce a core message from clinical practice: GLP-1s without lifestyle change are not the shortcut people hope they will be.
📌 Get Matched with a Dietitian Today! (Virtual Options Available)
https://casespecificnutrition.com/match 📲 Follow Us on Instagram!
https://www.instagram.com/casespecificnutrition
More
CGMs and GLP-1s are everywhere right now, but should everyone be using them? In this episode, Andrew Wade, registered dietitian and CEO of Case Specific Nutrition, is joined by Brad and Hillary, both registered dietitians and lead clinicians at their own offices, to break down the most common question they hear in practice: should non-diabetics get a CGM to improve their health? Together, they explore how to interpret CGM data, the risks of chasing numbers without context, and what happens when "optimization" replaces foundational health behaviors. The conversation also covers the growing role of GLP-1 medications, recent updates around accessibility and pricing, and why cost reductions can be both a promising step forward and a potential risk depending on how these medications are used. Brad and Hillary react to the explosion of GLP-1 content on social media, including patches, supplements, and "natural" protocols, and unpack ingredient obsessions like probiotics and Akkermansia. Through real client stories, they challenge weight loss expectations, highlight why eating more, building muscle, and fueling adequately can sometimes drive better results, and reinforce a core message from clinical practice: GLP-1s without lifestyle change are not the shortcut people hope they will be. 📌 Get Matched with a Dietitian Today! (Virtual Options Available) https://casespecificnutrition.com/match 📲 Follow Us on Instagram! https://www.instagram.com/casespecificnutrition